| |
 |
ARTICLES 
|
|
| Osteosarcoma: good news despite crude tools |
| JV Simone, WH Meyer, and MP Link |
|
JCO Jan 1 1992: 1–2.
[PDF]
|
 |
| Camptothecins |
| BA Chabner |
|
JCO Jan 1 1992: 3–4.
[PDF]
|
|
|
Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan- Kettering experience |
| |
PA Meyers, G Heller, J Healey, A Huvos, J Lane, R Marcove, A Applewhite, V Vlamis, and G Rosen |
| |
JCO Jan 1 1992: 5–15.
[Abstract]
[PDF]
|
|
|
A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer |
| |
M Fukuoka, H Niitani, A Suzuki, M Motomiya, K Hasegawa, Y Nishiwaki, T Kuriyama, Y Ariyoshi, S Negoro, and N Masuda |
| |
JCO Jan 1 1992: 16–20.
[Abstract]
[PDF]
|
|
|
Cushing's syndrome associated with ectopic corticotropin production and small-cell lung cancer |
| |
FA Shepherd, J Laskey, WK Evans, PE Goss, E Johansen, and F Khamsi |
| |
JCO Jan 1 1992: 21–27.
[Abstract]
[PDF]
|
|
|
Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study |
| |
HS Hochster, KM Kim, MD Green, RB Mann, RS Neiman, MM Oken, PA Cassileth, P Stott, P Ritch, and MJ O'Connell |
| |
JCO Jan 1 1992: 28–32.
[Abstract]
[PDF]
|
|
|
The use of interleukin-2 and lymphokine-activated killer cells for the treatment of patients with non-Hodgkin's lymphoma |
| |
JS Weber, JC Yang, SL Topalian, DJ Schwartzentruber, DE White, and SA Rosenberg |
| |
JCO Jan 1 1992: 33–40.
[Abstract]
[PDF]
|
|
|
Bone marrow transplantation versus high-dose cytarabine-based consolidation chemotherapy for acute myelogenous leukemia in first remission |
| |
GJ Schiller, SD Nimer, MC Territo, WG Ho, RE Champlin, and JL Gajewski |
| |
JCO Jan 1 1992: 41–46.
[Abstract]
[PDF]
|
|
|
High-risk multiple myeloma treated with high-dose melphalan |
| |
HM Lokhorst, OJ Meuwissen, LF Verdonck, and AW Dekker |
| |
JCO Jan 1 1992: 47–51.
[Abstract]
[PDF]
|
|
|
High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma |
| |
D Lienard, P Ewalenko, JJ Delmotte, N Renard, and FJ Lejeune |
| |
JCO Jan 1 1992: 52–60.
[Abstract]
[PDF]
|
|
|
Diagnosing infection in febrile granulocytopenic patients with indium- 111-labeled human immunoglobulin G |
| |
WJ Oyen, RA Claessens, JM Raemaekers, BE de Pauw, JW van der Meer, and FH Corstens |
| |
JCO Jan 1 1992: 61–68.
[Abstract]
[PDF]
|
|
|
Prognosis and other clinical correlates of pathologic review in stage I and II testicular carcinoma: a report from the Testicular Cancer Intergroup Study |
| |
IA Sesterhenn, RB Weiss, FK Mostofi, DM Stablein, RG Rowland, G Falkson, SE Rivkind, and NJ Vogelzang |
| |
JCO Jan 1 1992: 69–78.
[Abstract]
[PDF]
|
|
|
Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy |
| |
BD Minsky, AM Cohen, N Kemeny, WE Enker, DP Kelsen, B Reichman, L Saltz, ER Sigurdson, and J Frankel |
| |
JCO Jan 1 1992: 79–84.
[Abstract]
[PDF]
|
|
|
The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working Party [published erratum appears in J Clin Oncol 1992 May;10(5):867] |
| |
GM Mead, SP Stenning, MC Parkinson, A Horwich, SD Fossa, PM Wilkinson, SB Kaye, ES Newlands, and PA Cook |
| |
JCO Jan 1 1992: 85–94.
[Abstract]
[PDF]
|
|
|
Serum sialyl Tn as an independent predictor of poor prognosis in patients with epithelial ovarian cancer |
| |
H Kobayashi, T Terao, and Y Kawashima |
| |
JCO Jan 1 1992: 95–101.
[Abstract]
[PDF]
|
|
|
A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy |
| |
K Antman, L Ayash, A Elias, C Wheeler, M Hunt, JP Eder, BA Teicher, J Critchlow, J Bibbo, and LE Schnipper |
| |
JCO Jan 1 1992: 102–110.
[Abstract]
[PDF]
|
|
|
A study of fadrozole, a new aromatase inhibitor, in postmenopausal women with advanced metastatic breast cancer |
| |
JI Raats, G Falkson, and HC Falkson |
| |
JCO Jan 1 1992: 111–116.
[Abstract]
[PDF]
|
|
|
ICRF-187 permits longer treatment with doxorubicin in women with breast cancer [published erratum appears in J Clin Oncol 1992 May;10(5):867] |
| |
JL Speyer, MD Green, A Zeleniuch-Jacquotte, JC Wernz, M Rey, J Sanger, E Kramer, V Ferrans, H Hochster, and M Meyers |
| |
JCO Jan 1 1992: 117–127.
[Abstract]
[PDF]
|
|
|
A method of predicting adult height and obesity in long-term survivors of childhood acute lymphoblastic leukemia |
| |
MJ Schell, JJ Ochs, EA Schriock, and M Carter |
| |
JCO Jan 1 1992: 128–133.
[Abstract]
[PDF]
|
|
|
Comparative study of pamidronate disodium and etidronate disodium in the treatment of cancer-related hypercalcemia |
| |
R Gucalp, P Ritch, PH Wiernik, PR Sarma, A Keller, SP Richman, K Tauer, J Neidhart, LE Mallette, and R Siegel |
| |
JCO Jan 1 1992: 134–142.
[Abstract]
[PDF]
|
|
|
Phase I/II trial and pharmacokinetics of intrathecal diaziquone in refractory meningeal malignancies |
| |
SL Berg, FM Balis, S Zimm, RF Murphy, J Holcenberg, J Sato, G Reaman, P Steinherz, A Gillespie, and K Doherty |
| |
JCO Jan 1 1992: 143–148.
[Abstract]
[PDF]
|
|
|
Pain, opioid use, and survival in hospitalized patients with advanced cancer |
| |
FJ Brescia, RK Portenoy, M Ryan, L Krasnoff, and G Gray |
| |
JCO Jan 1 1992: 149–155.
[Abstract]
[PDF]
|
|
|
Acute lymphoblastic leukemia occurring as a second malignant neoplasm in childhood: report of three cases and review of the literature |
| |
SP Hunger, J Sklar, and MP Link |
| |
JCO Jan 1 1992: 156–163.
[Abstract]
[PDF]
|
|
|
Current attitudes and practice of American Society of Clinical Oncology- member clinical oncologists regarding cancer prevention and control |
| |
RT Chlebowski, J Sayre, M Frank-Stromborg, and LB Lillington |
| |
JCO Jan 1 1992: 164–168.
[Abstract]
[PDF]
|
|
| Amsacrine retains a special role supporting Food and Drug Administration approval |
| ZA Arlin, EJ Feldman, P Cook, T Ahmed, A Mittelman, HG Chun, C Puccio, and L Helson |
|
JCO Jan 1 1992: 169a.
[PDF]
|
|
| Cytarabine and CNS toxicity |
| WG Peters and R Willemze |
|
JCO Jan 1 1992: 169b.
[PDF]
|
|
| Lymphomatoid papulosis: response to treatment with recombinant interferon alfa-2b |
| SJ Proctor, GH Jackson, AL Lennard, and J Marks |
|
JCO Jan 1 1992: 170.
[PDF]
|
|
